环磷酰苷治疗病毒性心肌炎的疗效观察

Clinical Effect of Treatment of Viral Myocarditis with Cyclic Adenosine Monophosphate

目的观察环磷酰苷治疗病毒性心肌炎的临床效果。方法选择本院2016年6月—2017年6月收治的100例病毒性心肌炎患者为临床研究对象,根据入院顺序平均分成观察组与对照组,前者应用环磷酰苷治疗,后者应用常规方法治疗;观察两组患者治疗前后的临床指标波动状况,对比治疗效果与生活质量评分。结果治疗后观察组总有效率明显高于对照组,且观察组患者心肌酶指标明显好转,各项症状得到改善,优于对照组(P<0.05)。结论病毒性心肌炎采用环磷酰苷治疗,能够有效的提高治疗效果、缓解患者临床症状、降低心肌酶指数。

Objective To analyze the clinical effect of cyclophosphamide(CP)therapy for patients with viral myocarditis. Methods A total of 100 patients with viral myocarditis in our hospital from June 2016 to June 2017 were selected as the clinical research object,according to the order of admission,the patients were divided into observation group and control group,the former application of cyclophospha glycosides treatment,the latter used conventional treatment. Clinical indicators of two groups before and after the fluctuation treatment of patients,the rapeutic effect and the quality of life were compared in patients between the two groups. Results After treatment,the total effective rate of the observation group was significantly higher than that of the control group,and the myocardial enzymes of the observation group were significantly improved,the symptoms were improved,which was better than the control group(P<0.05). Conclusion The treatment of cyclophosphonoside in patients with viral myocarditis can effectively improve the therapeutic effect,relieve the clinical symptoms and reduce the myocardial enzyme index. Therefore,this method is worthy of extensive application.